NL-OMON47589已完成不适用
The OPTIMAL Study: a prospective cohort of patients with bone metastases of the long bones - OPTIMAL study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Aged 18 or older
- •- Radiographic or histologic proof of metastatic bone disease
- •- Histologic diagnosis of the primary tumour or * if the diagnosis is unknown - at least adequate diagnostic investigations into the origin of the metastasis (e.g. dissemination imaging, histology, biopsy)
- •- Bone metastasis deriving from the bones of the extremities
排除标准
- •- Primary bone tumours (benign and/or malignant)
- •- No informed consent signed
- •- Communication with patient is hampered (e.g. language barrier, severe cognitive impairment, dementia)
研究者
相似试验
招募中
不适用
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
尚未招募
Unknown
A Prospective Observational Study of patients who switched from SGLT2 inhibitor tablets to luseogliflozin OD film formulation in terms of feeling, Efficacy and Safety of taking the medicine.Type 2 Diabetes MellitusJPRN-UMIN000050476Seino internal Medicine Clinic60
已完成
不适用
Prospective Cohort Study: Whether or Not Patients Benefit From Participation Itself in Randomized-controlled TrialsBreast CancerJPRN-UMIN000020645SELECT BC executive committee68
已完成
不适用
Prospective Cohort Study: Whether or Not Patients Benefit From Participation Itself in Randomized-controlled Trials 2Breast CancerJPRN-UMIN000021099SELECT BC-CONFIRM executive committee44
已完成
不适用
A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agoniststype 2 diabetesJPRN-UMIN000048407Kanto Rosai Hospital65